USA – Amgen and Arrakis Therapeutics have announced a collaboration to develop RNA degrader therapeutics for a variety of difficult-to-drug targets. The collaboration will focus on developing a new class…
Read MoreAmgen collaborates with Arrakis to develop targeted RNA degraders
